2/10
08:00 am
enlv
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
Medium
Report
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
1/26
08:00 am
enlv
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
High
Report
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
1/23
06:51 pm
enlv
RAIN Hits All-Time High After WhiteBIT Listing, Gains 17% in 24 Hours [Yahoo! Finance]
High
Report
RAIN Hits All-Time High After WhiteBIT Listing, Gains 17% in 24 Hours [Yahoo! Finance]
1/23
08:00 am
enlv
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Medium
Report
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
1/12
07:17 am
enlv
Enlivex Therapeutics (NASDAQ:ENLV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Enlivex Therapeutics (NASDAQ:ENLV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/7
08:00 am
enlv
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
Medium
Report
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
12/13
04:13 am
enlv
Enlivex: A Necessary Update - This Is No Longer The Company We Covered In 2022 [Seeking Alpha]
Medium
Report
Enlivex: A Necessary Update - This Is No Longer The Company We Covered In 2022 [Seeking Alpha]
12/4
08:26 am
enlv
Greenberg Traurig Advises Enlivex in $212M Private Placement
Medium
Report
Greenberg Traurig Advises Enlivex in $212M Private Placement
12/4
08:00 am
enlv
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
Medium
Report
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
11/26
08:00 am
enlv
Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement
Medium
Report
Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement
11/25
07:31 am
enlv
Enlivex Therapeutics (NASDAQ:ENLV) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
Low
Report
Enlivex Therapeutics (NASDAQ:ENLV) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
11/24
11:04 am
enlv
Enlivex Therapeutics (NASDAQ:ENLV) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
High
Report
Enlivex Therapeutics (NASDAQ:ENLV) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
11/24
10:00 am
enlv
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors
High
Report
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors
11/24
07:55 am
enlv
Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board
Medium
Report
Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board
11/24
06:40 am
enlv
Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis
Medium
Report
Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis